Morbidity and mortality in the Wolfram syndrome

BT Kinsley, M Swift, RH Dumont, RG Swift - Diabetes care, 1995 - Am Diabetes Assoc
BT Kinsley, M Swift, RH Dumont, RG Swift
Diabetes care, 1995Am Diabetes Assoc
OBJECTIVE To determine the major causes of morbidity and mortality in the autosomal
recessive Wolfram syndrome, which is defined by diabetes and bilateral progressive optic
atrophy with onset in childhood or adolescence. RESEARCH DESIGN AND METHODS We
abstracted and reviewed the medical records of 68 confirmed cases of Wolfram syndrome
identified through a nationwide survey of endocrinologists, ophthalmologists, institutes, and
homes for the blind. We also reviewed all available autopsy records. RESULTS The most …
OBJECTIVE
To determine the major causes of morbidity and mortality in the autosomal recessive Wolfram syndrome, which is defined by diabetes and bilateral progressive optic atrophy with onset in childhood or adolescence.
RESEARCH DESIGN AND METHODS
We abstracted and reviewed the medical records of 68 confirmed cases of Wolfram syndrome identified through a nationwide survey of endocrinologists, ophthalmologists, institutes, and homes for the blind. We also reviewed all available autopsy records.
RESULTS
The most common causes of morbidity and mortality were the neurological manifestations of this syndrome and the complications of urinary tract atony. There was a lower frequency of diabetic ketoacidosis, no histologically proven diabetic glomerulosclerosis, and less severe, more slowly progressive, diabetic retinopathy than in classic type I diabetic patients. Mortality in Wolfram syndrome is much higher than in type I diabetes; 60% of Wolfram syndrome patients die by age 35. Recognition of these clinical differences from classic type I diabetes is important for the proper management of Wolfram syndrome patients.
CONCLUSIONS
Identification of Wolfram syndrome patients among all diabetic patients presenting in childhood or adolescence is important because the management of patients with this syndrome is different from that of patients with classic type I diabetes.
Am Diabetes Assoc